VeroScience ^Company

VeroScience is committed to developing novel, practical, and effective therapies for chronic debilitating human diseases such as Type 2 diabetes, metabolic syndrome, autoimmune disease, and cancer through interdisciplinary basic research. Their approach at achieving these goals focuses in large part upon readjusting aberrant central nervous system (CNS) modulation of neuroendocrine activities etiologic in or supportive of these disease states. VeroScience researchers study biological clocks in vertebrates and their organizational influence on neuroendocrine regulation of physiology to develop new treatment strategies for metabolic and immune disorders.